Astera Labs, Inc. $ALAB Shares Bought by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. raised its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 11,529.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,376 shares of the company’s stock after acquiring an additional 38,046 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Astera Labs were worth $6,384,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Hilltop National Bank raised its holdings in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new stake in Astera Labs in the 4th quarter valued at about $33,000. Wexford Capital LP acquired a new stake in Astera Labs in the 3rd quarter valued at about $39,000. Finally, National Bank of Canada FI raised its holdings in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $306.88 on Friday. The firm has a 50 day simple moving average of $170.39 and a 200-day simple moving average of $159.79. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $315.81. The stock has a market cap of $52.60 billion, a price-to-earnings ratio of 207.35, a price-to-earnings-growth ratio of 3.94 and a beta of 3.35.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the company posted $0.33 EPS. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have commented on ALAB. Roth Mkm reiterated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Citigroup increased their price objective on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. Finally, Morgan Stanley increased their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $233.75.

Read Our Latest Stock Analysis on ALAB

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
  • Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
  • Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
  • Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.03, for a total value of $701,105.15. Following the completion of the sale, the director owned 63,639 shares of the company’s stock, valued at $12,729,709.17. This represents a 5.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 14,076 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the completion of the sale, the general counsel directly owned 104,139 shares of the company’s stock, valued at approximately $24,137,337.42. This trade represents a 11.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 1,915,461 shares of company stock worth $358,508,976. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.